Clearpoint Neuro Inc
NASDAQ:CLPT

Watchlist Manager
Clearpoint Neuro Inc Logo
Clearpoint Neuro Inc
NASDAQ:CLPT
Watchlist
Price: 12.74 USD -1.16% Market Closed
Market Cap: 351.6m USD
Have any thoughts about
Clearpoint Neuro Inc?
Write Note

Intrinsic Value

CLPT's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CLPT stock under the Base Case scenario is 6.14 USD. Compared to the current market price of 12.74 USD, Clearpoint Neuro Inc is Overvalued by 52%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CLPT Intrinsic Value
6.14 USD
Overvaluation 52%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Clearpoint Neuro Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CLPT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CLPT?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Clearpoint Neuro Inc

Provide an overview of the primary business activities
of Clearpoint Neuro Inc.

What unique competitive advantages
does Clearpoint Neuro Inc hold over its rivals?

What risks and challenges
does Clearpoint Neuro Inc face in the near future?

Has there been any significant insider trading activity
in Clearpoint Neuro Inc recently?

Summarize the latest earnings call
of Clearpoint Neuro Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Clearpoint Neuro Inc.

Provide P/S
for Clearpoint Neuro Inc.

Provide P/E
for Clearpoint Neuro Inc.

Provide P/OCF
for Clearpoint Neuro Inc.

Provide P/FCFE
for Clearpoint Neuro Inc.

Provide P/B
for Clearpoint Neuro Inc.

Provide EV/S
for Clearpoint Neuro Inc.

Provide EV/GP
for Clearpoint Neuro Inc.

Provide EV/EBITDA
for Clearpoint Neuro Inc.

Provide EV/EBIT
for Clearpoint Neuro Inc.

Provide EV/OCF
for Clearpoint Neuro Inc.

Provide EV/FCFF
for Clearpoint Neuro Inc.

Provide EV/IC
for Clearpoint Neuro Inc.

Show me price targets
for Clearpoint Neuro Inc made by professional analysts.

What are the Revenue projections
for Clearpoint Neuro Inc?

How accurate were the past Revenue estimates
for Clearpoint Neuro Inc?

What are the Net Income projections
for Clearpoint Neuro Inc?

How accurate were the past Net Income estimates
for Clearpoint Neuro Inc?

What are the EPS projections
for Clearpoint Neuro Inc?

How accurate were the past EPS estimates
for Clearpoint Neuro Inc?

What are the EBIT projections
for Clearpoint Neuro Inc?

How accurate were the past EBIT estimates
for Clearpoint Neuro Inc?

Compare the revenue forecasts
for Clearpoint Neuro Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Clearpoint Neuro Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Clearpoint Neuro Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Clearpoint Neuro Inc compared to its peers.

Compare the P/E ratios
of Clearpoint Neuro Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Clearpoint Neuro Inc with its peers.

Analyze the financial leverage
of Clearpoint Neuro Inc compared to its main competitors.

Show all profitability ratios
for Clearpoint Neuro Inc.

Provide ROE
for Clearpoint Neuro Inc.

Provide ROA
for Clearpoint Neuro Inc.

Provide ROIC
for Clearpoint Neuro Inc.

Provide ROCE
for Clearpoint Neuro Inc.

Provide Gross Margin
for Clearpoint Neuro Inc.

Provide Operating Margin
for Clearpoint Neuro Inc.

Provide Net Margin
for Clearpoint Neuro Inc.

Provide FCF Margin
for Clearpoint Neuro Inc.

Show all solvency ratios
for Clearpoint Neuro Inc.

Provide D/E Ratio
for Clearpoint Neuro Inc.

Provide D/A Ratio
for Clearpoint Neuro Inc.

Provide Interest Coverage Ratio
for Clearpoint Neuro Inc.

Provide Altman Z-Score Ratio
for Clearpoint Neuro Inc.

Provide Quick Ratio
for Clearpoint Neuro Inc.

Provide Current Ratio
for Clearpoint Neuro Inc.

Provide Cash Ratio
for Clearpoint Neuro Inc.

What is the historical Revenue growth
over the last 5 years for Clearpoint Neuro Inc?

What is the historical Net Income growth
over the last 5 years for Clearpoint Neuro Inc?

What is the current Free Cash Flow
of Clearpoint Neuro Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Clearpoint Neuro Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Clearpoint Neuro Inc

Current Assets 46.6m
Cash & Short-Term Investments 32.8m
Receivables 3.5m
Other Current Assets 10.2m
Non-Current Assets 6m
PP&E 4.9m
Intangibles 758k
Other Non-Current Assets 385k
Current Liabilities 16.7m
Accounts Payable 822k
Accrued Liabilities 4.8m
Other Current Liabilities 11.1m
Non-Current Liabilities 3.7m
Other Non-Current Liabilities 3.7m
Efficiency

Earnings Waterfall
Clearpoint Neuro Inc

Revenue
28.1m USD
Cost of Revenue
-11.3m USD
Gross Profit
16.8m USD
Operating Expenses
-35.4m USD
Operating Income
-18.6m USD
Other Expenses
593k USD
Net Income
-18m USD

Free Cash Flow Analysis
Clearpoint Neuro Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

ClearPoint Neuro reported a record revenue of $7.9 million for Q2 2024, marking a 32% increase from the previous year. This significant growth was driven by advancements across all four of their key pillars: biologics and drug delivery, neurosurgery navigation, therapy, and achieving global scale. Key highlights include a 148% increase in capital equipment and software revenue, a 47% reduction in operating cash burn, and a gross margin improvement to 63%. The company raised its full-year revenue guidance to a range of $30 to $33 million, forecasting a growth of 25% to 38% for the year.

What is Earnings Call?
Fundamental Scores

CLPT Profitability Score
Profitability Due Diligence

Clearpoint Neuro Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
ROIC is Increasing
30/100
Profitability
Score

Clearpoint Neuro Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

CLPT Solvency Score
Solvency Due Diligence

Clearpoint Neuro Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
43/100
Solvency
Score

Clearpoint Neuro Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CLPT Price Targets Summary
Clearpoint Neuro Inc

Wall Street analysts forecast CLPT stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLPT is 12.07 USD with a low forecast of 10.1 USD and a high forecast of 15.75 USD.

Lowest
Price Target
10.1 USD
21% Downside
Average
Price Target
12.07 USD
5% Downside
Highest
Price Target
15.75 USD
24% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CLPT?

Click here to dive deeper.

Dividends

Clearpoint Neuro Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CLPT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CLPT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

CLPT News

Other Videos

Profile

Clearpoint Neuro Inc Logo
Clearpoint Neuro Inc

Country

United States of America

Industry

Health Care

Market Cap

351.5m USD

Dividend Yield

0%

Description

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.

Contact

CALIFORNIA
Solana Beach
120 S. Sierra Avenue, Suite 100
+19499006833.0
www.clearpointneuro.com

IPO

2019-07-03

Employees

80

Officers

President, CEO & Director
Mr. Joseph Michael Burnett
Chief Financial Officer
Mr. Danilo D'Alessandro
Chief Business Officer
Mr. Jeremy Stigall
Chief Operating Officer
Mr. Mazin Sabra
General Counsel & Secretary
Ms. Ellisa Cholapranee
Vice President of Marketing
Ms. Jacqueline Keller

See Also

Discover More
What is the Intrinsic Value of one CLPT stock?

The intrinsic value of one CLPT stock under the Base Case scenario is 6.14 USD.

Is CLPT stock undervalued or overvalued?

Compared to the current market price of 12.74 USD, Clearpoint Neuro Inc is Overvalued by 52%.

Back to Top